Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Male Breast Carcinoma|Recurrent Breast Carcinoma|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer
Interventions: DRUG: Pazopanib Hydrochloride|PROCEDURE: Dynamic Contrast-Enhanced Magnetic Resonance Imaging|OTHER: Pharmacological Study|OTHER: Laboratory Biomarker Analysis
Sponsor: National Cancer Institute (NCI)